Right now the price per share is 11,70$, Zentalis Pharmaceuticals Llc, with address at 530 SEVENTH AVENUE SUITE 2201, NEW YORK, New York, 10018, United States, is a publicly traded company and its visible heads at the moment are Anthony Y. Sun (Executive Chairman, President & CEO), Kevin D. Bunker (Chief Operating Officer), Melissa B. Epperly (Chief Financial Officer), Orna Bornstein (Vice President-Clinical Operations). Focused on Specialty Chemicals was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 11,78$ moving between 11,45$ and 12,11$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
